NAD+ precursor at the center of modern longevity research — the most-discussed anti-aging supplement of the decade.
Nicotinamide Mononucleotide (NMN) is a naturally occurring molecule found in small amounts in foods such as broccoli, avocado and edamame, and produced inside the body as a direct precursor to NAD+ (nicotinamide adenine dinucleotide) — a coenzyme required by every cell for energy production, DNA repair and cellular signalling. NAD+ levels decline steadily with age, and this decline is one of the most consistently observed biochemical changes in aging across species. NMN supplementation is designed to raise NAD+ levels by supplying the body with the direct building block it needs, one metabolic step closer than the related compound Nicotinamide Riboside (NR).
NAD+ fuels sirtuins (the same "longevity gene" family activated by resveratrol) and PARP enzymes involved in DNA repair. As NAD+ falls with age, these repair and metabolic systems become less efficient — a pattern seen in muscle, liver and brain tissue in animal studies. Restoring NAD+ levels in mice has been shown to improve mitochondrial function, muscle endurance, insulin sensitivity and markers of vascular aging, which is what drove the surge of interest in NMN and NR as human supplements.
Multiple human clinical trials have confirmed that oral NMN reliably raises blood NAD+ levels and is well tolerated at typical doses. Evidence for downstream effects in humans — improved muscle strength, insulin sensitivity and endurance — is more mixed and comes largely from smaller or short-duration trials; long-term outcome data (lifespan, disease risk) in humans doesn't yet exist and won't for years. This is an active, fast-moving research area, so it's worth treating NMN as a promising NAD+-support supplement backed by strong mechanistic and animal data, rather than a proven life-extension intervention in people.
In-depth science-based articles about this product
Learn more about how NMN (Nicotinamide Mononucleotide) supports these health areas